Literature DB >> 3840766

Effects of BM 15.766 on serum lipids in rats.

J Pill, F H Schmidt, K Stegmeier, E C Witte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840766     DOI： 10.1055/s-2007-1013600

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  6 in total

1.  Smith-Lemli-Opitz syndrome: deficient delta 7-reductase activity in cultured skin fibroblasts and chorionic villus fibroblasts and its application to pre- and postnatal detection.

Authors:  R J Wanders; G J Romeijn; F Wijburg; R C Hennekam; J de Jong; R A Wevers; G Dacremont
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

2.  Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis.

Authors:  J Pill; E C Witte; F H Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.

Authors:  G Xu; G Salen; S Shefer; G C Ness; T S Chen; Z Zhao; G S Tint
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

4.  RPR 101821, a new potent cholesterol-lowering agent: inhibition of squalene synthase and 7-dehydrocholesterol reductase.

Authors:  D Amin; R Z Rutledge; S J Needle; D J Hele; K Neuenswander; R C Bush; G E Bilder; M H Perrone
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.

Authors:  S Shefer; G Salen; A K Batta; A Honda; G S Tint; M Irons; E R Elias; T C Chen; M F Holick
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

6.  Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.

Authors:  Robert Blassberg; James I Macrae; James Briscoe; John Jacob
Journal:  Hum Mol Genet       Date:  2015-12-18       Impact factor: 6.150
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.